Filing Details

Accession Number:
0001127602-10-007206
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-03 12:00:00
Reporting Period:
2010-03-01
Filing Date:
2010-03-03
Accepted Time:
2010-03-03 16:39:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145197 Insulet Corp PODD Surgical & Medical Instruments & Apparatus (3841) 043523891
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1395780 Ruthann Depietro C/O Insulet Corporation
9 Oak Park Drive
Bedford MA 01730
Vice President Of Quality No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-01 1,500 $5.94 1,820 No 4 M Direct
Common Stock Disposition 2010-03-01 1,500 $15.00 320 No 4 S Direct
Common Stock Acquisiton 2010-03-01 8,000 $0.00 8,320 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2010-03-01 1,500 $0.00 1,500 $5.94
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2010-03-01 8,000 $0.00 8,000 $15.16
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
70,141 2016-03-06 No 4 M Direct
8,000 2020-03-01 No 4 A Direct
Footnotes
  1. This option may be exercised at any time, whether vested or not, but, upon termination of employment, we may repurchase any unvested shares at the exercise price paid for the shares. This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal monthly installments each month thereafter for 36 months, subject to continued employment.
  2. This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
  3. The 8,000 restricted stock units vest one-third of the total units on the first anniversary date of the grant and one-third each on the second and third anniversaries of the date of the grant. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
  4. Includes an aggregate of 320 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan: 20 shares acquired on December 31, 2007; 48 shares acquired on June 30, 2008; 100 shares acquired on December 31, 2008; 99 shares acquired on June 30, 2009; and 53 shares acquired on December 31, 2009.